Literature DB >> 28608532

Heteromers of μ opioid and dopamine D1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner.

Yi-Min Tao1, Chuan Yu1, Wei-Sheng Wang1, Yuan-Yuan Hou1, Xue-Jun Xu1, Zhi-Qiang Chi1, Yu-Qiang Ding2, Yu-Jun Wang1, Jing-Gen Liu1.   

Abstract

BACKGROUND AND
PURPOSE: Exposure to opiates induces locomotor sensitization in rodents, which has been proposed to correspond to the compulsive drug-seeking behaviour. Numerous studies have demonstrated that locomotor sensitization can occur in a dopamine transmission-independent manner; however, the underlying mechanisms are unclear. EXPERIMENTAL APPROACH: Co-immunoprecipitation, BRET and cross-antagonism assays were used to demonstrate the existence of receptor heterodimers. Function of heterodimers was evaluated by behavioural studies of locomotor sensitization. KEY
RESULTS: The dopamine D1 receptor antagonist SCH23390 antagonized the signalling initiated by stimulation of μ opioid receptors with agonists in transfected cells expressing two receptors and in striatal tissues from wild-type but not D1 receptor knockout (KO) mice, suggesting that SCH23390 modified μ receptor function via receptor heteromers, as the ability of an antagonist of one of the receptors to inhibit signals originated by stimulation of the partner receptor was a characteristic of receptor heteromers. The existence of μ receptor-D1 receptor heterodimers was further supported by biochemical and biophysical assays. In vivo, when dopamine release was absent (by destruction of the dopaminergic projection from the ventral tegmental area to the striatum), SCH23390 still significantly inhibited μ receptor agonist-induced behavioural responses in rats. Additionally, we demonstrated that D1 or μ receptor KO mice and thus unable to form μ receptor-D1 receptor heterodimers, failed to show locomotor sensitization to morphine. CONCLUSION AND IMPLICATIONS: Our results suggest that μ receptor-D1 receptor heterodimers may be involved in the dopamine-independent expression of locomotor sensitization to opiates.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28608532      PMCID: PMC5554314          DOI: 10.1111/bph.13908

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  74 in total

1.  Heterodimerization of mu and delta opioid receptors: A role in opiate synergy.

Authors:  I Gomes; B A Jordan; A Gupta; N Trapaidze; V Nagy; L A Devi
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

2.  Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons.

Authors:  Kelly A Berg; Matthew P Rowan; Achla Gupta; Teresa A Sanchez; Michelle Silva; Ivone Gomes; Blaine A McGuire; Philip S Portoghese; Kenneth M Hargreaves; Lakshmi A Devi; William P Clarke
Journal:  Mol Pharmacol       Date:  2011-11-09       Impact factor: 4.436

3.  Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens.

Authors:  D S Segal; R Kuczenski
Journal:  Brain Res       Date:  1992-04-17       Impact factor: 3.252

Review 4.  G Protein-Coupled Receptor Heteromers.

Authors:  Ivone Gomes; Mohammed Akli Ayoub; Wakako Fujita; Werner C Jaeger; Kevin D G Pfleger; Lakshmi A Devi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-22       Impact factor: 13.820

Review 5.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

6.  Stimulant effects of enkephalin microinjection into the dopaminergic A10 area.

Authors:  C L Broekkamp; A G Phillips; A R Cools
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

7.  Neuroanatomical focus for morphine and enkephalin-induced hypermotility.

Authors:  A Pert; C Sivit
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

8.  Dopaminergic D-1 receptors: essential role in morphine-induced hypermotility.

Authors:  R Longoni; L Spina; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  Loss of locomotor sensitisation in response to morphine in D1 receptor deficient mice.

Authors:  A Becker; G Grecksch; J Kraus; B Peters; H Schroeder; S Schulz; V Höllt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-05       Impact factor: 3.000

Review 10.  Role of ERK in cocaine addiction.

Authors:  Lin Lu; Eisuke Koya; Haifeng Zhai; Bruce T Hope; Yavin Shaham
Journal:  Trends Neurosci       Date:  2006-11-07       Impact factor: 13.837

View more
  12 in total

1.  Co-localization of mu-opioid and dopamine D1 receptors in the medial preoptic area and bed nucleus of the stria terminalis across seasonal states in male European starlings.

Authors:  Jeremy A Spool; Devin P Merullo; Changjiu Zhao; Lauren V Riters
Journal:  Horm Behav       Date:  2018-11-20       Impact factor: 3.587

2.  Differences in dopamine and opioid receptor ratios in the nucleus accumbens relate to physical contact and undirected song in pair-bonded zebra finches.

Authors:  Sarah J Alger; Sharon A Stevenson; Ana Armenta Vega; Cynthia A Kelm-Nelson; Charity Vilchez Juang; Lauren V Riters
Journal:  Behav Neurosci       Date:  2021-10-07       Impact factor: 1.912

3.  Selective Manipulation of G-Protein γ7 Subunit in Mice Provides New Insights into Striatal Control of Motor Behavior.

Authors:  Gloria Brunori; Oliver B Pelletier; Anna M Stauffer; Janet D Robishaw
Journal:  J Neurosci       Date:  2021-09-20       Impact factor: 6.167

Review 4.  Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor.

Authors:  Jia-Jia Zhang; Chang-Geng Song; Ji-Min Dai; Ling Li; Xiang-Min Yang; Zhi-Nan Chen
Journal:  MedComm (2020)       Date:  2022-06-22

5.  Facilitating mGluR4 activity reverses the long-term deleterious consequences of chronic morphine exposure in male mice.

Authors:  Jerome A J Becker; Lucie P Pellissier; Yannick Corde; Thibaut Laboute; Audrey Léauté; Jorge Gandía; Julie Le Merrer
Journal:  Neuropsychopharmacology       Date:  2020-12-21       Impact factor: 8.294

6.  The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids.

Authors:  Rebecca Speltz; Mary M Lunzer; Sarah S Shueb; Eyup Akgün; Rachelle Reed; Alex Kalyuzhny; Philip S Portoghese; Donald A Simone
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

7.  Chronic developmental lead exposure increases μ-opiate receptor levels in the adolescent rat brain.

Authors:  Damaris Albores-Garcia; Jennifer L McGlothan; Zoran Bursac; Tomás R Guilarte
Journal:  Neurotoxicology       Date:  2020-11-25       Impact factor: 4.294

Review 8.  Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo.

Authors:  Muzeyyen Ugur; Lyes Derouiche; Dominique Massotte
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

9.  Receptor-Receptor Interactions of G Protein-Coupled Receptors in the Carotid Body: A Working Hypothesis.

Authors:  Andrea Porzionato; Elena Stocco; Diego Guidolin; Luigi Agnati; Veronica Macchi; Raffaele De Caro
Journal:  Front Physiol       Date:  2018-06-07       Impact factor: 4.566

Review 10.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.